|
CYBA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.39540000005023E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.60909999996828E-07 |
| Normal-vs-Stage2 |
6.471900E-02 |
| Normal-vs-Stage3 |
3.389400E-04 |
| Normal-vs-Stage4 |
1.263180E-03 |
| Stage1-vs-Stage2 |
8.323900E-02 |
| Stage1-vs-Stage3 |
1.671210E-01 |
| Stage1-vs-Stage4 |
6.756200E-02 |
| Stage2-vs-Stage3 |
3.903200E-01 |
| Stage2-vs-Stage4 |
5.619800E-01 |
| Stage3-vs-Stage4 |
6.823800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.69309999997758E-06 |
| Normal-vs-AfricanAmerican |
3.627900E-02 |
| Normal-vs-Asian |
1.999960E-04 |
| Caucasian-vs-AfricanAmerican |
2.426200E-01 |
| Caucasian-vs-Asian |
5.643200E-01 |
| AfricanAmerican-vs-Asian |
1.411400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.09550000018766E-07 |
| Normal-vs-Female |
2.48519999999086E-05 |
| Male-vs-Female |
1.211710E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.8887999999111E-07 |
| Normal-vs-Age(41-60Yrs) |
1.191220E-04 |
| Normal-vs-Age(61-80Yrs) |
2.696400E-03 |
| Normal-vs-Age(81-100Yrs) |
2.301000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.743100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.681900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.621200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.952200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.301600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.379190E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.093400E-01 |
| Classical-VS-Follicular |
7.920800E-01 |
| Classical-VS-Other |
5.303400E-01 |
| Classical-VS-Normal |
2.46199999998087E-06 |
| Tall-VS-Follicular |
2.077600E-01 |
| Tall-VS-Other |
2.004400E-01 |
| Tall-VS-Normal |
3.645800E-02 |
| Follicular-VS-Other |
7.369200E-01 |
| Follicular-VS-Normal |
6.765000E-04 |
| Other-VS-Normal |
2.346300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.34689999954053E-07 |
| Normal-vs-N1 |
4.0104999999846E-06 |
| N0-vs-N1 |
5.548200E-01 |
|
|
